{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:40:15Z","timestamp":1788021615574,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82103869"],"award-info":[{"award-number":["No. 82103869"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Postdoctoral Research Foundation of Heilongjiang","award":["No. LBH-QY22004"],"award-info":[{"award-number":["No. LBH-QY22004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93550-z","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T15:39:41Z","timestamp":1741793981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of sialic acid supplementation in early life in autism model rats"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiaolei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"93550_CR1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nature21369","volume":"542","author":"HC Hazlett","year":"2017","unstructured":"Hazlett, H. C. et al. Early brain development in infants at high risk for autism spectrum disorder. Nature 542, 348\u2013351 (2017).","journal-title":"Nature"},{"key":"93550_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.mm7201a1","volume":"72","author":"MJ Maenner","year":"2023","unstructured":"Maenner, M. J. et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2020. Morb. Mortal. Wkl. Rep. Surveill. Sum. 72, 1\u201314 (2023).","journal-title":"Morb. Mortal. Wkl. Rep. Surveill. Sum."},{"key":"93550_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-030-30402-7_4","volume":"24","author":"R Bhandari","year":"2020","unstructured":"Bhandari, R., Paliwal, J. K. & Kuhad, A. Neuropsychopathology of autism spectrum disorder: Complex interplay of genetic, epigenetic, and environmental factors. Adv. Neurobiol. 24, 97\u2013141 (2020).","journal-title":"Adv. Neurobiol."},{"key":"93550_CR4","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.3390\/ijms20194947","volume":"20","author":"M Paolillo","year":"2019","unstructured":"Paolillo, M. & Schinelli, S. Extracellular matrix alterations in metastatic processes. Int. J. Mol. Sci. 20, 4947 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"93550_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.mam.2016.07.001","volume":"51","author":"CA Dwyer","year":"2016","unstructured":"Dwyer, C. A. & Esko, J. D. Glycan susceptibility factors in autism spectrum disorders. Mol. Asp. Med. 51, 104\u2013114 (2016).","journal-title":"Mol. Asp. Med."},{"key":"93550_CR6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ng.3578","volume":"48","author":"C van Karnebeek","year":"2016","unstructured":"van Karnebeek, C. et al. NANS-mediated synthesis of sialic acid is required for brain and skeletal development. Nat. Genet. 48, 777\u2013784 (2016).","journal-title":"Nat. Genet."},{"key":"93550_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10719-018-9832-9","volume":"35","author":"C Sato","year":"2018","unstructured":"Sato, C. & Hane, M. Mental disorders and an acidic glycan-from the perspective of polysialic acid (PSA\/polySia) and the synthesizing enzyme, ST8SIA2. Glycoconj. J. 35, 353\u2013373 (2018).","journal-title":"Glycoconj. J."},{"issue":"1","key":"93550_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1042\/BST20180330","volume":"47","author":"S Iqbal","year":"2019","unstructured":"Iqbal, S., Ghanimi Fard, M., Everest-Dass, A., Packer, N. H. & Parker, L. M. Understanding cellular glycan surfaces in the central nervous system. Biochem. Soc. Trans. 47(1), 89\u2013100 (2019).","journal-title":"Biochem. Soc. Trans."},{"key":"93550_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.brainres.2017.10.027","volume":"1678","author":"X Yang","year":"2018","unstructured":"Yang, X. et al. Sialic acid and anti-ganglioside antibody levels in children with autism spectrum disorders. Brain Res. 1678, 273\u2013277 (2018).","journal-title":"Brain Res."},{"key":"93550_CR10","doi-asserted-by":"publisher","first-page":"e21013","DOI":"10.1097\/MD.0000000000021013","volume":"99","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. The level of GNE and its relationship with behavioral phenotypes in children with autism spectrum disorder. Medicine 99, e21013 (2020).","journal-title":"Medicine"},{"key":"93550_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bbr.2018.11.012","volume":"359","author":"X Yang","year":"2019","unstructured":"Yang, X. et al. The association between NCAM1 levels and behavioral phenotypes in children with autism spectrum disorder. Behav. Brain Res. 359, 234\u2013238 (2019).","journal-title":"Behav. Brain Res."},{"key":"93550_CR12","doi-asserted-by":"publisher","first-page":"112756","DOI":"10.1016\/j.bbr.2020.112756","volume":"393","author":"M Mansouri","year":"2020","unstructured":"Mansouri, M., Pouretemad, H., Roghani, M., Wegener, G. & Ardalan, M. Autistic-like behaviours and associated brain structural plasticity are modulated by oxytocin in maternally separated rats. Behav. Brain Res. 393, 112756 (2020).","journal-title":"Behav. Brain Res."},{"key":"93550_CR13","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1021\/acschemneuro.0c00672","volume":"12","author":"R Singla","year":"2021","unstructured":"Singla, R. et al. Inhibition of the ERK1\/2 phosphorylation by dextromethorphan protects against core autistic symptoms in VPA induced autistic rats. In silico and in vivo drug repurposition study. ACS Chem. Neurosci. 12, 1749\u20131767 (2021).","journal-title":"ACS Chem. Neurosci."},{"key":"93550_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.lfs.2017.01.012","volume":"173","author":"H Wu","year":"2017","unstructured":"Wu, H. et al. Fingolimod (FTY720) attenuates social deficits, learning and memory impairments, neuronal loss and neuroinflammation in the rat model of autism. Life Sci. 173, 43\u201354 (2017).","journal-title":"Life Sci."},{"key":"93550_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.9758\/cpn.2019.17.3.415","volume":"17","author":"E Demirci","year":"2019","unstructured":"Demirci, E., Guler, Y., Ozmen, S., Canpolat, M. & Kumandas, S. Levels of salivary sialic acid in children with autism spectrum disorder; Could it be related to stereotypes and hyperactivity?. Clin. Psychopharmacol. Neurosci. 17, 415\u2013422 (2019).","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"93550_CR16","doi-asserted-by":"publisher","first-page":"870374","DOI":"10.3389\/fpsyt.2022.870374","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang, H. et al. Correlation between sialidase NEU1 mRNA expression changes in autism spectrum disorder. Front. Psychiatry 13, 870374 (2022).","journal-title":"Front. Psychiatry"},{"key":"93550_CR17","doi-asserted-by":"publisher","first-page":"641027","DOI":"10.3389\/fnut.2021.641027","volume":"8","author":"D Bian","year":"2021","unstructured":"Bian, D., Wang, X., Huang, J., Chen, X. & Li, H. Maternal Neu5Ac supplementation during pregnancy improves offspring learning and memory ability in rats. Front. Nutr. 8, 641027 (2021).","journal-title":"Front. Nutr."},{"key":"93550_CR18","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3390\/nu10101519","volume":"10","author":"E Oliveros","year":"2018","unstructured":"Oliveros, E. et al. Sialic acid and sialylated oligosaccharide supplementation during lactation improves learning and memory in rats. Nutrients 10, 1519 (2018).","journal-title":"Nutrients"},{"key":"93550_CR19","doi-asserted-by":"publisher","first-page":"912671","DOI":"10.3389\/fnmol.2022.912671","volume":"15","author":"D Krgovic","year":"2022","unstructured":"Krgovic, D. et al. Impaired neurodevelopmental genes in Slovenian autistic children elucidate the comorbidity of autism with other developmental disorders. Front. Mol. Neurosci. 15, 912671 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"93550_CR20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/j.1601-183X.2010.00635.x","volume":"9","author":"L Calandreau","year":"2010","unstructured":"Calandreau, L., M\u00e1rquez, C., Bisaz, R., Fantin, M. & Sandi, C. Differential impact of polysialyltransferase ST8SiaII and ST8SiaIV knockout on social interaction and aggression. Genes Brain Behav. 9, 958\u2013967 (2010).","journal-title":"Genes Brain Behav."},{"key":"93550_CR21","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/ajmg.a.36345","volume":"164A","author":"B Kamien","year":"2014","unstructured":"Kamien, B. et al. Characterization of a 520 kb deletion on chromosome 15q26.1 including ST8SIA2 in a patient with behavioral disturbance, autism spectrum disorder, and epilepsy. Am. J. Med. Genet. A 164A, 782\u2013788 (2014).","journal-title":"Am. J. Med. Genet. A"},{"key":"93550_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038172","volume":"7","author":"EZ McAuley","year":"2012","unstructured":"McAuley, E. Z. et al. Identification of sialyltransferase 8B as a generalized susceptibility gene for psychotic and mood disorders on chromosome 15q25-26. PloS one 7, e38172 (2012).","journal-title":"PloS one"},{"key":"93550_CR23","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.bbrc.2016.08.079","volume":"478","author":"M Hane","year":"2016","unstructured":"Hane, M., Kitajima, K. & Sato, C. Effects of intronic single nucleotide polymorphisms (iSNPs) of a polysialyltransferase, ST8SIA2 gene found in psychiatric disorders on its gene products. Biochem. Biophys. Res. Commun. 478, 1123\u20131129 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"93550_CR24","doi-asserted-by":"publisher","first-page":"100892","DOI":"10.1016\/j.mam.2020.100892","volume":"79","author":"C Sato","year":"2021","unstructured":"Sato, C. & Kitajima, K. Polysialylation and disease. Mol. Asp. Med. 79, 100892 (2021).","journal-title":"Mol. Asp. Med."},{"key":"93550_CR25","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/glycob\/cwv049","volume":"25","author":"M Hane","year":"2015","unstructured":"Hane, M. et al. Protective effects of polysialic acid on proteolytic cleavage of FGF2 and proBDNF\/BDNF. Glycobiology 25, 1112\u20131124 (2015).","journal-title":"Glycobiology"},{"key":"93550_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/bs.vh.2016.11.004","volume":"104","author":"C Sato","year":"2017","unstructured":"Sato, C. Releasing mechanism of neurotrophic factors via polysialic acid. Vitam. Horm. 104, 89\u2013112 (2017).","journal-title":"Vitam. Horm."},{"key":"93550_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105606","volume":"163","author":"S Camuso","year":"2022","unstructured":"Camuso, S., La Rosa, P., Fiorenza, M. T. & Canterini, S. Pleiotropic effects of BDNF on the cerebellum and hippocampus: Implications for neurodevelopmental disorders. Neurobiol. Dis. 163, 105606 (2022).","journal-title":"Neurobiol. Dis."},{"key":"93550_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","volume":"185","author":"CS Wang","year":"2022","unstructured":"Wang, C. S., Kavalali, E. T. & Monteggia, L. M. BDNF signaling in context: From synaptic regulation to psychiatric disorders. Cell 185, 62\u201376 (2022).","journal-title":"Cell"},{"key":"93550_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/aur.2622","volume":"15","author":"C Shu","year":"2022","unstructured":"Shu, C., Green Snyder, L., Shen, Y. & Chung, W. K. Imputing cognitive impairment in SPARK, a large autism cohort. Autism Res. 15, 156\u2013170 (2022).","journal-title":"Autism Res."},{"key":"93550_CR30","doi-asserted-by":"publisher","first-page":"105728","DOI":"10.1016\/j.isci.2022.105728","volume":"26","author":"M Sgritta","year":"2023","unstructured":"Sgritta, M. et al. Impaired synaptic plasticity in an animal model of autism exhibiting early hippocampal GABAergic-BDNF\/TrkB signaling alterations. iScience 26, 105728 (2023).","journal-title":"iScience"},{"key":"93550_CR31","doi-asserted-by":"publisher","first-page":"9558","DOI":"10.3390\/ijms24119558","volume":"24","author":"Z Guo","year":"2023","unstructured":"Guo, Z. Ganglioside GM1 and the central nervous system. Int. J. Mol. Sci. 24, 9558 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"93550_CR32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.bbagen.2007.09.008","volume":"1780","author":"G Nores","year":"2008","unstructured":"Nores, G. et al. Anti-GM1 antibodies as a model of the immune response to self-glycans. Biochim. Biophys. Acta 1780, 538\u2013545 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"93550_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13229-016-0109-5","volume":"7","author":"F Gevi","year":"2016","unstructured":"Gevi, F., Zolla, L., Gabriele, S. & Persico, A. M. Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism. Mol. Autism 7, 47 (2016).","journal-title":"Mol. Autism"},{"key":"93550_CR34","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/aur.2311","volume":"13","author":"B Ritz","year":"2020","unstructured":"Ritz, B. & Yan, Q. Untargeted metabolomics screen of mid-pregnancy maternal serum and autism in offspring. Autism Res. 13, 1258\u20131269 (2020).","journal-title":"Autism Res."},{"key":"93550_CR35","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.3390\/nu14142896","volume":"14","author":"L Jennings","year":"2022","unstructured":"Jennings, L. & Basiri, R. Amino acids, B vitamins, and choline may independently and collaboratively influence the incidence and core symptoms of autism spectrum disorder. Nutrients 14, 2896 (2022).","journal-title":"Nutrients"},{"key":"93550_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00726-016-2332-y","volume":"49","author":"HF Zheng","year":"2017","unstructured":"Zheng, H. F., Wang, W. Q., Li, X. M., Rauw, G. & Baker, G. B. Body fluid levels of neuroactive amino acids in autism spectrum disorders: A review of the literature. Amino Acids 49, 57\u201365 (2017).","journal-title":"Amino Acids"},{"key":"93550_CR37","first-page":"412","volume":"10","author":"M Randazzo","year":"2023","unstructured":"Randazzo, M. et al. neuroactive amino acid profile in autism spectrum disorder: Results from a clinical sample. Children (Basel, Switzerland) 10, 412 (2023).","journal-title":"Children (Basel, Switzerland)"},{"key":"93550_CR38","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.febslet.2012.01.049","volume":"586","author":"TA Clayton","year":"2012","unstructured":"Clayton, T. A. Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism. FEBS Lett. 586, 956\u2013961 (2012).","journal-title":"FEBS Lett."},{"key":"93550_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jtcme.2022.03.001","volume":"13","author":"A Mehra","year":"2023","unstructured":"Mehra, A. et al. Gut microbiota and autism spectrum disorder: From pathogenesis to potential therapeutic perspectives. J. Trad. Complement. Med. 13, 135\u2013149 (2023).","journal-title":"J. Trad. Complement. Med."},{"key":"93550_CR40","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1021\/acs.jproteome.9b00581","volume":"19","author":"C Mu","year":"2020","unstructured":"Mu, C. et al. Metabolic framework for the improvement of autism spectrum disorders by a modified ketogenic diet: A pilot study. J. Proteome Res. 19, 382\u2013390 (2020).","journal-title":"J. Proteome Res."},{"key":"93550_CR41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/jpm13020252","volume":"13","author":"NR Indika","year":"2023","unstructured":"Indika, N. R. et al. The rationale for vitamin, mineral, and cofactor treatment in the precision medical care of autism spectrum disorder. J. Personal. Med. 13, 252 (2023).","journal-title":"J. Personal. Med."},{"key":"93550_CR42","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3390\/nu14061280","volume":"14","author":"K Sahin","year":"2022","unstructured":"Sahin, K. et al. Therapeutic effects of a novel form of biotin on propionic acid-induced autistic features in rats. Nutrients 14, 1280 (2022).","journal-title":"Nutrients"},{"key":"93550_CR43","volume-title":"Molecular Imaging and Contrast Agent Database (MICAD)","author":"K Leung","year":"2004","unstructured":"Leung, K. Molecular Imaging and Contrast Agent Database (MICAD) (National Center for Biotechnology Information, 2004)."},{"key":"93550_CR44","doi-asserted-by":"publisher","first-page":"111246","DOI":"10.1016\/j.celrep.2022.111246","volume":"40","author":"B Dai","year":"2022","unstructured":"Dai, B. et al. Responses and functions of dopamine in nucleus accumbens core during social behaviors. Cell Rep. 40, 111246 (2022).","journal-title":"Cell Rep."},{"key":"93550_CR45","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1007\/s11011-023-01287-3","volume":"38","author":"E Oge-Enver","year":"2023","unstructured":"Oge-Enver, E. et al. Urinary neopterin and biopterin indicate that inflammation has a role in autism spectrum disorder. Metab. Brain Dis. 38, 2645\u20132651 (2023).","journal-title":"Metab. Brain Dis."},{"key":"93550_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0304-3940(97)00976-2","volume":"241","author":"S Messahel","year":"1998","unstructured":"Messahel, S. et al. Urinary levels of neopterin and biopterin in autism. Neurosci. Let. 241, 17\u201320 (1998).","journal-title":"Neurosci. Let."},{"key":"93550_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41390-018-0224-4","volume":"85","author":"R Cayabyab","year":"2019","unstructured":"Cayabyab, R. & Ramanathan, R. High unbound bilirubin for age: A neurotoxin with major effects on the developing brain. Pediatric Res. 85, 183\u2013190 (2019).","journal-title":"Pediatric Res."},{"key":"93550_CR48","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1080\/10715762.2016.1239821","volume":"50","author":"A Anwar","year":"2016","unstructured":"Anwar, A. et al. Quantitation of plasma thiamine, related metabolites and plasma protein oxidative damage markers in children with autism spectrum disorder and healthy controls. Free Radic. Res. 50, S85\u2013S90 (2016).","journal-title":"Free Radic. Res."},{"key":"93550_CR49","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1080\/1028415X.2022.2101976","volume":"26","author":"AHB Rashaid","year":"2023","unstructured":"Rashaid, A. H. B. et al. Profiling plasma levels of thiamine and histamine in Jordanian children with autism spectrum disorder (ASD): Potential biomarkers for evaluation of ASD therapies and diet. Nutr. Neurosci. 26, 842\u2013849 (2023).","journal-title":"Nutr. Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93550-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93550-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93550-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T01:37:14Z","timestamp":1741829834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93550-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93550"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93550-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments were approved by the Ethics Committee of Qiqihar Medical University and operated in strict accordance with its relevant regulations (No. QMU-AECC-2021\u201362). Our study was in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"8576"}}